Gold Holds Steady as Markets Eye USIran Peace Talks India Government Plans Overhaul of Tax Administration to Ensure Smooth GST Rollout Exclusive Tulsi Gabbard Resigns as Trumps Intelligence Chief to Care for Husband with Bone Cancer Putin Nuclear Doctrine Update Roils Markets Stock Futures Bond Yields Decline Market Bubble Risks Key Factors That Could Trigger a Correction Nvidias Blockbuster Earnings Reveal 200 Billion Opportunity and Edge Computing Focus Despite China Concession JTAI Q1 2026 Earnings EPS Falls Short of Estimates Stock Rises 217 SBSW Q2 2022 Earnings EPS Misses Estimates Stock Reacts Negatively SMR Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Operations HEI Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Aerospace Demand PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues CWEN Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement EZGO Technologies Slumps 68 as Shares Approach Critical Support Level Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted MaxCyte Inc MXCT Surges 787 as Shares Test Key Resistance Level StandardAero Inc SARO Surges 241 as Shares Approach Key Resistance Level PROG Holdings PRG Holds Steady Near 3346 Amid Modest Trading Activity SpaceX Launches Starship Test Flight After Previous Scrubbed Attempt High Templar Tech Limited HTT Q1 2023 Earnings Positive EPS Result Drives Sharp Stock Rally Altria MO Holds Near Support Amid Modest Decline Key Levels in Focus Tactile Systems Technology Q1 2026 Earnings NarrowerThanExpected Loss Masks Lack of Revenue Details RWTN Q1 2026 Earnings EPS Misses Estimates Stock Rises 085 ACN Q1 2026 Earnings EPS Beats Estimates by 213 Amid Consulting Demand CYN Q1 2026 Earnings EPS Beats Estimates Despite No Reported Revenue Disc Medicine IRON Q1 2026 Earnings SmallerThanExpected Loss Reflects Continued Cost Discipline in PreRevenue Stage Virgin Galactic SPCE Q1 2026 Earnings A NarrowerThanExpected Loss Ignites Shareholder Optimism Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD